These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8257824)

  • 21. Cytotoxic activity of human lymphocytes against differentiated intestinal tumour cell lines.
    Anelli R; Placido R; Sambuy Y; Bach S; Di Massimo A; Colizzi V
    Immunology; 1993 Jan; 78(1):166-9. PubMed ID: 8436403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of natural killer cells.
    Ortaldo JR; Herberman RB
    Annu Rev Immunol; 1984; 2():359-94. PubMed ID: 6399848
    [No Abstract]   [Full Text] [Related]  

  • 23. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
    Weiss L; Reich S; Mandelboim O; Slavin S
    Bone Marrow Transplant; 2004 Jun; 33(11):1137-41. PubMed ID: 15077128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cells in human health and disease.
    Orange JS; Ballas ZK
    Clin Immunol; 2006 Jan; 118(1):1-10. PubMed ID: 16337194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulation.
    Atzpodien J; Bührer C; Gulati SC; Wisniewski D; Oz S; Kirchner H; Benter T; Poliwoda H; Welte K; Clarkson B
    Haematol Blood Transfus; 1989; 32():273-80. PubMed ID: 2625252
    [No Abstract]   [Full Text] [Related]  

  • 28. Mistaken notions about natural killer cells.
    Yokoyama WM
    Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytotoxic activity of the effector cells as a factor in protective immunity in helminthiases (a review of the literature)].
    Leĭkina ES
    Med Parazitol (Mosk); 1983; 52(2):58-65. PubMed ID: 6343821
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future.
    Vivier E; Anfossi N
    Nat Rev Immunol; 2004 Mar; 4(3):190-8. PubMed ID: 15039756
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of inhibitory receptors for MHC class I molecules on T cells.
    Huard B
    Crit Rev Immunol; 2000; 20(6):471-6. PubMed ID: 11396682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Natural killer cells--important in the immunologic defense].
    Løvik G; Rolstad B
    Tidsskr Nor Laegeforen; 2000 May; 120(13):1542-6. PubMed ID: 10916477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.
    Grunfeld C; Palladino MA
    Adv Intern Med; 1990; 35():45-71. PubMed ID: 2405602
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphokine-activated-killer-mediated lysis of cells infected with typhus group rickettsiae can be inhibited by OKT3 monoclonal antibody.
    Carl M; Dasch GA
    Infect Immun; 1986 Jul; 53(1):226-8. PubMed ID: 3087881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of splenic natural killer cells and prothymocytes.
    Koo GC; Cayre Y; Mittl LR
    Cell Immunol; 1981 Jul; 62(1):164-71. PubMed ID: 6114798
    [No Abstract]   [Full Text] [Related]  

  • 37. Natural killer cells: definition, heterogeneity, lytic mechanism, functions and clinical application. Highlights of the Fifth International Workshop on natural killer cells, Hilton Head Island, N.C., March 1988.
    Lotzová E; Ades EW
    Nat Immun Cell Growth Regul; 1989; 8(1):1-9. PubMed ID: 2785639
    [No Abstract]   [Full Text] [Related]  

  • 38. [T-cells in the immune system. 2: Control of bacterial and viral infections].
    Uhl D
    Med Monatsschr Pharm; 1991 Jul; 14(7):195-6. PubMed ID: 1832203
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunodeficiency in Down's syndrome: analysis by OKT monoclonal antibodies.
    Bertotto A; Gerli R; Fabietti G; Arcangeli CD; Bianchi S; Vaccaro R
    Thymus; 1984; 6(6):365-7. PubMed ID: 6084348
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural killer cells.
    Lanier LL; Phillips JH
    Curr Opin Immunol; 1992 Feb; 4(1):38-42. PubMed ID: 1596367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.